Over-the-counter medications are becoming increasingly available to the general public. One of the issues facing clinicians working with transplant recipients is how to advise patients regarding management of symptoms associated with common ailments. Minimal literature is available to assist the transplant coordinators in this process. This article describes the usual immunosuppressants prescribed for transplant recipients and the over-the-counter medications used to manage these symptoms, and provides recommendations for over-the-counter medications with the least side effects.
Get full access to this article
View all access options for this article.
References
1.
LakeKNolenJSlakerR. Over-the-counter medications in cardiac transplant recipients: Guidelines for use. Ann Pharmacother.1992;26(12):1566–1575.
2.
Food and Medication Administration.FDA proposes new, easy to understand labeling for OTC medications. Accessed at: http://www.hhs.gov. Accessed February 26, 1997.
United Network for Organ Sharing.Data highlights-The 1998 Report of Center Specific Grant and Patient Survival Rates. Accessed at: http://www.inos.org/Data/survival_execsum_dat.htm. Accessed April 3, 1998.
5.
JindalRSidnerRMilgromM. Post-transplant diabetes mellitus. The role of immunosuppression. Med Safety.1997:16(4):242–257.
6.
GeyerN. Corticosteroid therapy after organ transplant. Nurs News (South Africa).1996;20(10):38–41.
7.
HalloranP. Immunosuppressive agents in clinical trials in transplantation. Am J Med Sci.1997;313(5):283–288.
8.
DelginJVallerandA. Davis's Medication Guide for Nurses.4th ed.Philadelphia, Pa: Davis; 1995.
9.
JahansouzFKriettJ. Transplantation: A review of immunosuppressive agents. Crit Care Nurse Q.1993;15(4):13–22.
10.
MinD. Neoral: A microemulsion cyclosporine. J Transplant Coordination.1996;6(1):5–8.
11.
TrezepaczPDiMartiniATringaliR. Psychopharmacologic issues in organ transplantation. Part 1: Pharmacokinetics in organ failure and psychiatric aspects of immunosuppressants and anti-infectious agents. Psychosomatics.1993;34(3):199–207.
12.
ShaferMWilliamsL. Nursing implications of immunosuppression in transplantation. Nurs Clin North Am.1991;26(2):291–311.
13.
SmithS. Ten years of orthoclone OKT3 (muromonab-CD3): A review. J Transplant Coordination.1996;6(3):109–119.
14.
LakeKKilkenneyJ. The pharmacokinetics and pharmacodynamics of immunosuppressive agents. Crit Care Nurse Clin North Am.1992;4(2):205–221.
15.
HoffmanRReederS. Mycophenolate mofetil (CellCept): The newest immunosuppressant. Crit Care Nurse.1998;18(3):50–57.
16.
American Pharmaceutical Association.Handbook of Nonprescription Medications.11th ed.Washington, DC: United Book Press; 1996.
17.
GriffithH. Complete Guide to Prescription and Nonprescription Medications.New York, NY: Putnum; 1994.
18.
OlsonJ. Clinical Pharmacology Made Ridiculously Simple.Miami, Fla: MedMaster, Inc;1997.
19.
LatnerA. OTCs get boost from pharmacist recommendations. Pharmacy Times.1997;10(supp):6–30.
